tirzepatide for kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Weight Loss/Diabetic Drug Tirzepatide Slashes

The device patent portfolio for FlexTouch covers the dose-setting mechanism, the cartridge coupling system, the audible dose confirmation mechanism, and the pressure-minimizing injection feature Novo markets as reducing injection force

Between 2024 and 2025, premiums for FEHB plans increased by 11.2%, the largest increase in FEHB premiums in more than two decades

The 20 most intense multiply charged ions (z 2) were sequentially isolated and fragmented in the octopole collision cell by higher-energy collisional dissociation (HCD) using normalized collision energy of 32 with an AGC target of 1 10 5 and 200 normalized AGC targets (%) at 45,000 resolutions

Efficacy : Orlistat reduces fat absorption but doesnt directly address sugar cravings